PNEUMOCOCCAL DISEASE
Clinical trials for PNEUMOCOCCAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL DISEASE trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to shield babies from pneumonia and meningitis
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine (PG4) to see if it is as safe as the current pneumococcal vaccine (Prevnar 20) in healthy infants. About 2400 babies around 2 months old will receive either the new or current vaccine at 2, 4, 6, and 12-15 months of age. The goal is to protect again…
Matched conditions: PNEUMOCOCCAL DISEASE
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:57 UTC
-
Can a pneumonia shot protect the most vulnerable kids?
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests whether a pneumococcal vaccine (Pneumosil) can produce a strong immune response in children aged 6-59 months hospitalized with severe acute malnutrition. 214 children in Timor-Leste will be randomly assigned to receive either the pneumococcal vaccine or a typhoid…
Matched conditions: PNEUMOCOCCAL DISEASE
Phase: PHASE4 • Sponsor: Nick Fancourt • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:56 UTC